Breaks Categories: News

WednesdayFeb 18, 2026 10:59 am

NetworkNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Advances Beacon Gold Mill Restart in Val-d’Or Mining Camp 

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.  LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) provided an update on progress toward restarting its 100%-owned Beacon Gold Mill in Val-d’Or, Québec, alongside advancement of its Preliminary Economic Assessment and near-term production strategy. The Company reported that electrical upgrades and winterization improvements are largely complete, key mechanical systems have been refurbished and inspected, and modern safety enhancements have been installed, with approximately 30% of the restart budget deployed to date under cost control. Positioned within the prolific Abitibi Greenstone Belt and supported by its Swanson Gold Deposit located 60 kilometers from the mill,…

Continue Reading

WednesdayFeb 18, 2026 10:14 am

NetworkNewsBreaks – Wearable Devices Ltd. (NASDAQ: WLDS) Featured in AINewsWire Editorial on Next Wave of AI Investment

Wearable Devices (NASDAQ: WLDS) announced its placement in an editorial published by AINewsWire (“AINW”), one of more than 75 brands within the Dynamic Brand Portfolio at IBN (InvestorBrandNetwork), examining how closing the gap between human intent and machine execution may define the next phase of artificial intelligence investment. The article highlights the emerging need for high-fidelity, real-time intent capture as AI advances toward autonomous, agentic systems and notes Wearable Devices’ launch of ai6 Labs, a neural AI ecosystem designed to bridge intent and digital reality through integrated research, commercialization and technologies such as its Large MUAP Model, positioning the Company as infrastructure for…

Continue Reading

WednesdayFeb 18, 2026 9:50 am

NetworkNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical and med-tech company advancing cancer treatments, announced the appointment of Sidney Braun as Chief Executive Officer of its Liora Technologies Europe Ltd. subsidiary. Braun, who previously facilitated LIXTE’s November 2025 acquisition of Liora’s assets, brings more than 20 years of healthcare operational and strategic advisory experience and will lead advancement of Liora’s LiGHT System, an electronically controlled proton therapy platform designed to enhance tumor treatment. Management said the appointment supports its strategy to scale the technology and pursue a recurring revenue model within the radiotherapy segment of cancer care. To view the…

Continue Reading

WednesdayFeb 18, 2026 9:30 am

NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Late-Stage Biotech M&A Trends

Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in an editorial published by BioMedWire, one of more than 75 brands within the Dynamic Brand Portfolio at IBN (InvestorBrandNetwork), highlighting the growing focus in biotech mergers and acquisitions on de-risked, late-stage assets with clinical validation. The article, titled “Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A,” examines how pharmaceutical companies and investors are prioritizing programs with established safety and efficacy data, placing companies such as Oncotelic, with multiple clinical- and late-stage oncology and central nervous system programs, in alignment with current M&A trends as it advances its…

Continue Reading

WednesdayFeb 18, 2026 9:20 am

NetworkNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Reports Fiscal Q3 2026 Revenue Up 14% and Net Income Up 341%

Earth Science Tech (OTC: ETST) reported financial and operational results for the third fiscal quarter ended Dec. 31, 2025, with revenue of $8.4 million, up 14.1% year over year, gross profit of $6.4 million reflecting a 76.3% margin, and net income of $910,000, up 341% from the prior-year period. Adjusted EBITDA totaled $1.2 million, total assets increased to $8.1 million, and the company repurchased and retired 3.7 million shares during the first nine months of fiscal 2026, while ending the quarter with $416,000 in cash, $773,000 in working capital and no bank debt as management cited continued operating leverage and…

Continue Reading

WednesdayFeb 18, 2026 9:20 am

NetworkNewsBreaks – Nevada Organic Phosphate Inc. (CSE: NOP; OTCQB: NOPFF) Prepares for 2026 Murdock Mountain Drill Program Expansion

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.  Nevada Organic Phosphate (CSE: NOP; OTCQB: NOPFF) announced that field preparations are underway for the continuation of its Murdock Mountain drill program, with mobilization currently estimated for mid- to late-March 2026. The 2026 campaign is designed to extend the successful 2025 program westward, with plans to construct at least five additional drill pads along the remaining five-kilometer strike length and drill multiple holes per pad to further evaluate the continuity, thickness and grade of the 6.6-kilometer phosphate-bearing horizon. The Company said updated climate access modeling suggests heavy equipment access could begin as early…

Continue Reading

WednesdayFeb 18, 2026 9:10 am

NetworkNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Raises Preliminary FY 2025 Revenue to $38-$40 Million, Reaffirms $200 Million FY 2026 Target

Datavault AI (NASDAQ: DVLT) updated its preliminary, unaudited fiscal 2025 revenue estimate to $38 million to $40 million, exceeding its prior $30 million estimate by up to 33%, with midpoint growth of approximately 1,300% year over year, driven by customer tech-licensing fees and tokenization and monetization services from its Data Science Group. The company also reaffirmed its anticipated fiscal 2026 revenue target of $200 million, representing projected year-over-year growth of 400% to 426%, and said it plans to file its audited 2025 financial results with the SEC next month. To view the full press release, visit https://nnw.fm/HHnvH About Datavault AI…

Continue Reading

TuesdayFeb 17, 2026 3:32 pm

NetworkNewsBreaks – Globavend Holdings Limited (NASDAQ: GVH) Reports 42.5% Revenue Growth for Fiscal 2025 

Globavend Holdings (NASDAQ: GVH) reported financial results for the year ended Sept. 30, 2025, with revenue rising 42.5% year over year to $23.6 million. The company said it handled an average of 10,394 packages per day, up 69.4% from the prior year, while average daily revenue per freight weight increased 12.7%. Net income totaled $0.68 million. During the year, Globavend established a subsidiary in China and built out corporate infrastructure to support expansion, as management cited capital markets support and a growing pipeline positioning the company for continued revenue growth into 2026 and beyond. To view the full press release, visit https://nnw.fm/AA46K About Globavend Holdings Limited Globavend Holdings Limited,…

Continue Reading

TuesdayFeb 17, 2026 3:20 pm

NetworkNewsBreaks – MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Accelerates Lawson Natural Hydrogen Development, Launches 3D Seismic Program

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.  MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced an accelerated strategy to advance commercial evaluation of its Lawson Natural Hydrogen Discovery near Central Butte, Saskatchewan, and to pursue multiple strategic partnerships tied to the 475-kilometer Genesis Trend. The company has contracted Tetra Tech to conduct a 47-square-kilometer 3D seismic survey beginning the week of Feb. 23, 2026, with all permits secured, to support resource modeling and guide a confirmatory well. Concurrent laboratory analyses are underway, while more than 80 additional prospective structures along the Genesis Trend are being prioritized for a…

Continue Reading

TuesdayFeb 17, 2026 2:40 pm

NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway 

NRx Pharmaceuticals (NASDAQ: NRXP) announced completion of an in-person Type C guidance meeting with the U.S. Food and Drug Administration, attended by leadership from the Division of Psychiatry Products, Office of Neuroscience and Center for Drug Evaluation and Research. Based on oral guidance, the company believes it has a path to file a New Drug Application for NRX-100, a preservative-free ketamine formulation, supported by existing adequate and well-controlled trials and confirmatory evidence from more than 65,000 patients in a Real World Evidence dataset, while also seeking a broader indication for treatment-resistant depression with suicidality. The FDA advised that no additional nonclinical or bridging studies would be required, and…

Continue Reading